Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 55 of 1,261
  1. US 12251561

    Minimally invasive dermal electroporation device

    Inovio Pharmaceuticals, Inc. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  2. US 12252488

    HPK1 antagonists and uses thereof

    Nimbus Saturn, Inc. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  3. US 12252493

    Imidazo[1,2-c]pyrimidine derivatives as PRC2 inhibitors for treating cancer

    Mirati Therapeutics, Inc. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  4. US 12252497

    Ras inhibitors

    Revolution Medicines, Inc. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  5. US 12251440

    Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

    REGENERON PHARMACEUTICALS, INC. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  6. US 12251432

    Biomarkers and immunogenic compositions for filarial parasites

    The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  7. US 12251470

    Lipid nanoparticle formulations

    ARBUTUS BIOPHARMA CORPORATION Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  8. US 12251417

    Antimicrobial compounds from the genus Delftia

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  9. US 12251397

    Cross-linked hyaluronic acids and combinations with PRP/BMC

    REGEN LAB SA Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  10. US 12251378

    Long-acting local anesthetic formulation

    UNIVERSITY OF CONNECTICUT Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  11. US 12251387

    Substituted quinoxalines and benzo[c][1,2,5]oxadiazoles as DNA-PK inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  12. US 12251468

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  13. US 12252492

    Substituted fused pyrrolo-diazepinones and uses thereof

    Northwestern University Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  14. US 12251472

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  15. US 12252544

    Anti-CD63 antibodies, conjugates, and uses thereof

    REGENERON PHARMACEUTICALS, INC. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  16. US 12252550

    Antibodies that bind to C1S and uses thereof

    DIANTHUS THERAPEUTICS OPCO, INC. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  17. US 12251395

    RNAS for complement inhibition

    Apellis Pharmaceuticals, Inc. Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  18. US 12252714

    Halogenation of complex organic compounds

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  19. US 12252515

    Compositions and methods for inhibiting Wnt signaling

    The Regents of the University of California Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  20. US 12252480

    Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide

    The Board of Regents of the University of Texas System Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  21. US 12251478

    Bioactive polymeric dressing for accelerated wound closure

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  22. US 12251379

    Methods of inhibiting formation of alpha synuclein aggregates

    The Regents of the University of California Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  23. US 12251449

    Synthetic multidomain peptide biomaterials that inhibit inducible nitric oxide synthase

    The Board of Regents of the University of Texas System Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted
  24. US 12252464

    Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids

    The Board of Regents of the University of Texas System Β· Granted Mar 18, 2025 Β· Expires Mar 13, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.